Episode Details
Back to Episodes
Cannabis Industry Mixed Signals: M&A Surge Amid U.S. Sales Slowdown and 2026 Tax Reform Hopes
Published 1 month, 3 weeks ago
Description
In the past 48 hours, the cannabis industry shows mixed signals with steady dealmaking amid weak U.S. sales and bullish stock activity. Tilray Brands grabbed headlines by acquiring BrewDog, a global craft beer brand, for 44 million USD on March 2, signaling convergence between alcohol and cannabis as Tilray expands beyond core products into beverages.[2] Verdant Capital Partners also agreed to buy Native Roots retail operations in Colorado on March 3, consolidating retail amid competitive pressures.[11]
Market movements highlight volatility: Tilray (TLRY), Canopy Growth (CGC), and Aurora Cannabis (ACB) led trading volume on March 3, driven by speculation on 2026 U.S. tax reforms that could reset valuations.[1] Sales data from BDSA for 15 U.S. states revealed February totals of 1.99 billion USD, up 2.7 percent year-over-year but down 3.6 percent sequentially, or up just 6.7 percent per day adjusted—pointing to softening demand despite Ohio's 27.3 percent growth post-adult-use launch.[5] No major price shifts or supply chain disruptions reported, though Missouri proposed rules for recalls and public company ownership.[3]
Regulatory fronts stayed active: Maryland advanced protections for off-duty medical cannabis use by firefighters, while Oregon rejected edibles restrictions.[3] JARS Cannabis deepened sports ties with Grand Rapids Gold on March 3, launching basketball promotions to boost community engagement as advertising limits persist.[4]
Compared to prior weeks, sales weakness echoes January slowdowns warned by analysts, but M&A picks up pace versus quieter deal flow earlier. Leaders like Tilray respond to challenges by diversifying into non-cannabis assets for stability, while retailers like JARS invest in experiential marketing. Europe's expansion continues with firms like Cantourage importing products, but U.S. softness tempers optimism. Overall, industry eyes federal shifts for upside amid tactical growth plays. (298 words)
For great deals today, check out https://amzn.to/44ci4hQ
This content was created in partnership and with the help of Artificial Intelligence AI
Market movements highlight volatility: Tilray (TLRY), Canopy Growth (CGC), and Aurora Cannabis (ACB) led trading volume on March 3, driven by speculation on 2026 U.S. tax reforms that could reset valuations.[1] Sales data from BDSA for 15 U.S. states revealed February totals of 1.99 billion USD, up 2.7 percent year-over-year but down 3.6 percent sequentially, or up just 6.7 percent per day adjusted—pointing to softening demand despite Ohio's 27.3 percent growth post-adult-use launch.[5] No major price shifts or supply chain disruptions reported, though Missouri proposed rules for recalls and public company ownership.[3]
Regulatory fronts stayed active: Maryland advanced protections for off-duty medical cannabis use by firefighters, while Oregon rejected edibles restrictions.[3] JARS Cannabis deepened sports ties with Grand Rapids Gold on March 3, launching basketball promotions to boost community engagement as advertising limits persist.[4]
Compared to prior weeks, sales weakness echoes January slowdowns warned by analysts, but M&A picks up pace versus quieter deal flow earlier. Leaders like Tilray respond to challenges by diversifying into non-cannabis assets for stability, while retailers like JARS invest in experiential marketing. Europe's expansion continues with firms like Cantourage importing products, but U.S. softness tempers optimism. Overall, industry eyes federal shifts for upside amid tactical growth plays. (298 words)
For great deals today, check out https://amzn.to/44ci4hQ
This content was created in partnership and with the help of Artificial Intelligence AI